New data into the connections between drug use and sexual behaviours among gay and bisexual men has been released in the latest research articles coming out of the Kirby Institute’s Flux Study. Three journal articles, all published in ...

Researchers from the Kirby Institute at UNSW Sydney welcome the listing of co-formulated tenofovir and emtricitabine, as HIV pre-exposure prophylaxis (PrEP) on the pharmaceutical benefits scheme (PBS) in March. The Federal Health ...

One of UNSW Sydney’s and Australia’s most distinguished academic leaders, Scientia Professor David Cooper, passed away on Sunday 18 March after a short illness. Professor Cooper was internationally renowned, initiating ground-breaking, ...

(Sydney, 19 March 2018) The Kirby Institute at UNSW Sydney is mourning the loss of our Director, Scientia Professor David Cooper, who passed away on Sunday afternoon after a short illness from a rare auto inflammatory disease. David’s

Unprecedented levels of immunosuppression in countries such as Australia and the US must be considered in planning for the real risk of smallpox re-emerging in the world, an expert in infectious diseases warned. “Smallpox was ...

PBAC recommendation facilitates equitable access to PrEP for people at high risk of HIV (Sydney, Friday 9 February 2018) Researchers from the Kirby Institute at UNSW Sydney welcome the recommendation from the Pharmaceutical Benefits ...

The Kirby Institute is pleased to announce that we are welcoming 14 new Scientia PhD scholars in 2018. These students will be supervised by Kirby Institute academics who are leaders in their fields and will contributes to research ...

(Port Moresby, Thursday 25 January 2018) Australian researchers from the Kirby Institute have collaborated with researchers at Papua New Guinea’s Institute of Medical Research and the US Centers for Disease Control and Prevention ...

The Kirby Institute’s infectious disease research collaboration with the University of Medicine 2 (UM2) in Yangon, Myanmar, continues to make strides in building research capacity in Myanmar. Since the formal launch of the ...

In November 2017, the US Clinical Practice Guidelines in Oncology were updated to list pomalidomide, an oral immune regulator, as the preferred regimen for relapsed Kaposi’s sarcoma (KS), based on a U.S. study led by the Kirby ...

The Kirby Institute will be closed over the Christmas/New Year break. Our last day of operations is Tuesday 19 December 2017 and we reopen Tuesday 2 January 2018. From all of us, we wish you a safe and happy festive ...

The Kirby Institute at UNSW Sydney has received $9,060,140 for a Program Grant to conduct research on improving the lives of people with problematic drug use. The funding, announced today by the National Health and Medical Research ...

We would like to congratulate our colleague, Dr Muhammad Jamil, on being one of two recipients of the 2017 Dean of Medicine’s Award for Outstanding Contribution to Research by a Higher Degree Research Student. Dr Jamil works with the ...

The Kirby Institute's Dr Angela Kelly-Hanku, from the Public Health Interventions Research Group, has been appointed a Scientia Fellowship by UNSW. This prestigious accolade is part of the University’s global drive to recruit the ...

In October, a team from the Biostatistics and Databases Program visited Indonesia to attend the TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) annual meeting. TREAT Asia is a collaborative network of clinics, ...

On Thursday 24 November, the Kirby Institute held its 6th Brett Tindall Memorial Lecture, our annual lecture awarded to a world leader in infectious disease research. The event was opened by Professor Andrew Grulich, and Associate ...

Australia’s world-first human papillomavirus (HPV) vaccination program will dramatically reduce the incidence of cancer of the cervix for several decades, according to new research published in the Journal of Infectious Diseases.

Federal Health Minister Greg Hunt has visited the Kirby Institute at UNSW Sydney to announce a $70 million funding boost to build the capacity of Australia’s next generation of medical researchers. The investment in the ...